This past month, an international panel of researchers published a landmark consensus in The Lancet — and with it, polycystic ovary syndrome officially became polyendocrine metabolic ovarian syndrome, or PMOS.
The name change matters and is exciting in my world because the name tells the truth about what happens beyond the ovaries, looking towards the root cause.
“Polycystic” pointed to a structural finding — cysts on ovaries — that was never really the point. “Polyendocrine metabolic” describes what’s actually happening: a multi-system dysfunction involving hormones, metabolism, and inflammation, operating in a loop that feeds itself.
For those of us practicing root-cause medicine, this isn’t new. The hormone-inflammation connection has always been central to how we interpret and treat reproductive disorders — PMOS, endometriosis, perimenopause, PMS autoimmune reactivity, postpartum recovery, and beyond. What the new name does is give patients and practitioners a shared language that actually reflects the body. Even if you don’t have PMOS, this inflammation – hormone connection matters.
Hormones and Inflammation Are Not Separate Systems
This is the foundational reframe: your hormones and your immune system are in constant conversation. They regulate each other, influence each other, and when one shifts, the other follows.
This bidirectional relationship — the hormone-inflammation axis — sits at the center of most reproductive health disorders. Disrupted inflammatory signaling impairs how hormones are synthesized, released, and received. Imbalanced hormones amplify inflammatory cascades. The result is a cycle that doesn’t resolve on its own, because neither side of the equation is being addressed.
Let’s break this down further.
Estrogen: Anti-Inflammatory at Physiologic Levels, Pro-Inflammatory in Excess
Estrogen has a nuanced relationship with inflammation. At healthy physiologic levels, estradiol suppresses key inflammatory signals — including interleukin-6 (IL-6) and tumor necrosis factor-alpha (TNF-α) — while supporting immune tolerance and antioxidant pathways.
The problem emerges when estrogen becomes elevated relative to progesterone — through metabolic dysfunction, impaired liver detoxification, excess adipose tissue, or environmental estrogen exposure. In that context, estrogen shifts from anti-inflammatory to inflammatory, activating COX-2 enzymes, stimulating mast cell activity, and increasing prostaglandin production. This is a major driver of dysmenorrhea, endometriosis progression, and the breast tenderness that many women experience in the luteal phase.
The takeaway: estrogen excess isn’t just a “hormone problem.” It’s an inflammatory trigger. And addressing it requires looking at detoxification capacity, gut health, and metabolic function — not just the hormone number itself.
Progesterone: Your Most Anti-Inflammatory Hormone
Progesterone is systematically underappreciated. Beyond its reproductive functions, it is one of the most potent natural anti-inflammatory agents in the body.
Progesterone inhibits NF-κB — the master regulator of inflammatory gene expression — and suppresses cytokines including IL-1β and TNF-α. During the luteal phase, adequate progesterone production helps reduce the inflammatory tone that builds during the follicular phase. It supports uterine tissue repair and is essential for implantation.
Luteal phase progesterone insufficiency — far more common than most practitioners test for — is associated with elevated systemic inflammation, worsened PMS symptoms, dysmenorrhea, and cycle irregularity. In perimenopausal women, the early decline of progesterone relative to estrogen is often the first signal that the hormone-inflammation axis is shifting.
Androgens, Insulin, and the PMOS Connection
In the new framework of PMOS, the interplay between androgens, insulin, and inflammation takes center stage.
Elevated androgens in women — particularly testosterone — coexist with insulin resistance, inflammatory cytokine production from adipose tissue, and oxidative stress. These aren’t parallel problems; they drive each other. Insulin resistance increases ovarian androgen production. Elevated androgens worsen insulin sensitivity. Both elevate CRP and IL-6, and both impair ovulation.
This is why targeting insulin and inflammation is non-negotiable in PMOS management. Diet, exercise, sleep, and specific nutraceuticals all work through this axis — and they all need to be deployed together.
Cortisol: The Axis That Hijacks Everything Else
Chronic stress does more than make you tired. It fundamentally alters the hormone-inflammation axis.
The hypothalamic-pituitary-adrenal (HPA) axis and the hypothalamic-pituitary-gonadal (HPG) axis — the one governing reproductive hormones — are directly coupled. When cortisol remains chronically elevated, it suppresses the pulsatile GnRH signaling that drives ovulation. It elevates inflammatory cytokines by two to three times their baseline. It disrupts sleep architecture, impairs detoxification, and depletes the precursors needed to produce progesterone and DHEA.
The clinical picture: women under sustained physiologic or psychological stress frequently present with luteal phase insufficiency, irregular cycles, worsening PMS, and a general sense of being “wired but depleted.” This isn’t a vague lifestyle observation — it’s a measurable hormonal and inflammatory cascade.
The Key Inflammatory Pathways Driving Reproductive Dysfunction
Understanding which pathways are activated helps clarify why targeted interventions work:
COX-1 and COX-2: These enzymes regulate prostaglandin synthesis. Excess COX-2 activity — driven by estrogen dominance, stress, and poor diet — is the primary mechanism behind painful periods, endometriosis lesion development, and pelvic inflammation. This is why NSAIDs offer symptomatic relief; they block COX. The root-cause approach is to reduce what’s activating COX-2 in the first place.
NF-κB: Often called the “master switch” of inflammation, NF-κB controls the expression of dozens of inflammatory genes. Hormonal imbalances, insulin resistance, oxidative stress, and gut permeability all feed into NF-κB activation. Many of the most effective nutritional and botanical interventions — omega-3 fatty acids, curcumin, magnesium — work in part by downregulating this pathway.
Cytokines — IL-6, IL-1β, TNF-α: Elevated cytokines impair follicular development, block ovulation, and interfere with implantation. In endometriosis, cytokine dysregulation is both a cause and a consequence of disease progression. In PMOS, chronic low-grade elevation of these markers reflects the metabolic inflammation driving the condition.
Exercise, Sleep, and HPA Axis Repair: The Foundation You Can’t Skip
This is where the conversation shifts from mechanism to action. Because addressing the hormone-inflammation cycle isn’t only about supplements and labs. The most potent interventions operate through lifestyle — and the evidence is more compelling than most people realize.
Exercise as Anti-Inflammatory Medicine
Moderate aerobic exercise reduces CRP by 30–40% and measurably lowers IL-6 and TNF-α. Resistance training supports muscle mass, improves insulin sensitivity, and helps regulate leptin signaling — all of which directly affect the hormone-inflammation axis.
The critical nuance: exercise intensity matters. Chronic high-intensity training without adequate recovery raises cortisol and can worsen the very cycle you’re trying to interrupt. The goal is exercising for your hormones — structured movement that builds metabolic capacity without adding to the HPA burden.
Sleep: The Cytokine Reset
Sleep deprivation raises inflammatory cytokines within 48 hours. This is not a subtle effect — it’s rapid, measurable, and clinically significant. Melatonin, produced during healthy sleep, also plays a direct role in ovarian function, egg quality, and inflammatory regulation.
Optimizing sleep architecture isn’t optional for women managing hormone-related inflammation. It’s foundational.
HPA Axis Repair: Cortisol Is a Lab Test, Not a Guess
Interventions targeting the stress-hormone-inflammation connection are highly effective — but they require knowing what the cortisol pattern actually looks like. The cortisol awakening response, measured via salivary testing, tells you whether the HPA axis is overactivated, blunted, or dysregulated. This determines whether you’re using adaptogens like ashwagandha (which reduces cortisol 14–28% in research settings) or addressing a more complex adrenal recovery pattern.
The broader HPA toolkit — mindfulness-based stress reduction, structured breathwork, yoga, and cognitive behavioral approaches — has demonstrated 20–30% cortisol reductions with consistent practice. These aren’t soft interventions. They change measurable inflammatory markers.
The Mosaic View: Why Nothing Works in Isolation
The rename from PCOS to PMOS is a signal that medicine is finally catching up to what integrative clinicians have been working with for decades — that these conditions don’t live in one system, one organ, or one lab value.
They live in the intersection.
Estrogen excess driven by impaired liver conjugation. Progesterone deficiency amplified by cortisol competition. Androgen elevation maintained by insulin resistance and inflammatory adipose tissue. Sleep disruption sustaining the cytokine environment that makes all of it worse.
Each piece connects to the others. Which means treatment has to be equally integrated — addressing detoxification, nutrition, circadian rhythm, stress physiology, and metabolic function as a coherent system, not a checklist.
This Is Exactly What the Forgotten Hormones Program Addresses
If you are looking to address the greater picture, how your hormones fit into the mosaic, check out our Forgotten Hormones Program. The Forgotten Hormones Program is a six-week, root-cause framework built around the foundations that directly stabilize the hormone-inflammation connection:
- Detoxification — supporting the liver and gut pathways that clear excess estrogen and reduce the inflammatory burden on the hormonal system
- Anti-inflammatory nutrition — dietary strategies that lower insulin, modulate the gut microbiome, and reduce the cytokine environment driving symptoms
- Circadian rhythm restoration — rebuilding the sleep-melatonin-cortisol rhythm that governs both HPA and HPG axis function
- HPA axis repair — targeted support for cortisol dysregulation, adrenal recovery, and the stress-hormone feedback loop
- Exercise for your hormones — structured movement that improves insulin and leptin sensitivity without increasing the HPA burden
If you’re navigating perimenopause, PMS or PMDD, PMOS, or the complex overlap where hormone dysfunction and inflammation feed each other — this is the clinical foundation that changes the trajectory.
Learn more about the Forgotten Hormones Program →